Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Gea-Banacloche Website

Juan C. Gea-Banacloche, M.D.

Selected Publications

1)  Callejas-Díaz A, Gea-Banacloche JC.
Clostridium difficile: Deleterious Impact on Hematopoietic Stem Cell Transplantation.
Curr Hematol Malig Rep. 9: 85-90, 2014.
[Journal]
2)  Gea-Banacloche JC.
Antiviral cell therapy: is this the future?.
Blood. 121: 5108-9, 2013.
[Journal]
3)  Cuellar-Rodriguez J, Connor D, Murray P, Gea-Banacloche J.
Discrepant results from sampling different lumens of multilumen catheters: the case for sampling all lumens.
Eur. J. Clin. Microbiol. Infect. Dis. [Epub ahead of print], 2013.
[Journal]
4)  Kochenderfer JN, Dudley ME, Carpenter RO, Kassim SH, Rose JJ, Telford WG, Hakim FT, Halverson DC, Fowler DH, Hardy NM, Mato AR, Hickstein DD, Gea-Banacloche JC, Pavletic SZ, Sportes C, Maric I, Feldman SA, Hansen BG, Wilder JS, Blacklock-Schuver B, Jena B, Bishop MR, Gress RE, Rosenberg SA.
Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation.
Blood. 122: 4129-39, 2013.
[Journal]
5)  Gea-Banacloche J.
Evidence-based approach to treatment of febrile neutropenia in hematologic malignancies.
Hematology Am Soc Hematol Educ Program. 2013: 414-22, 2013.
[Journal]
6)  Bhanushali MJ, Kranick SM, Freeman AF, Cuellar-Rodriguez JM, Battiwalla M, Gea-Banacloche JC, Hickstein DD, Pavletic S, Fahle G, Nath A.
Human herpes 6 virus encephalitis complicating allogeneic hematopoietic stem cell transplantation.
Neurology. 80: 1494-500, 2013.
[Journal]
7)  Baird K, Steinberg SM, Grkovic L, Pulanic D, Cowen EW, Mitchell SA, Williams KM, Datiles MB, Bishop R, Bassim CW, Mays JW, Edwards D, Cole K, Avila DN, Taylor T, Urban A, Joe GO, Comis LE, Berger A, Stratton P, Zhang D, Shelhamer JH, Gea-Banacloche JC, Sportes C, Fowler DH, Gress RE, Pavletic SZ.
National Institutes of Health chronic graft-versus-host disease staging in severely affected patients: organ and global scoring correlate with established indicators of disease severity and prognosis.
Biol. Blood Marrow Transplant. 19: 632-9, 2013.
[Journal]
8)  Fowler DH, Mossoba ME, Steinberg SM, Halverson DC, Stroncek D, Khuu HM, Hakim FT, Castiello L, Sabatino M, Leitman SF, Mariotti J, Gea-Banacloche JC, Sportes C, Hardy NM, Hickstein DD, Pavletic SZ, Rowley S, Goy A, Donato M, Korngold R, Pecora A, Levine BL, June CH, Gress RE, Bishop MR.
Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantation.
Blood. 121: 2864-74, 2013.
[Journal]
Click Here to View Collapsed Bibliography.

This page was last updated on 2/25/2014.